Global CAR T-Cell Immunotherapy Market Size, Status and Forecast 2024-2031

Report ID: 934849 | Published Date: Jan 2025 | No. of Page: 123 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Monotherapy
        1.2.3 Combination Therapy
    1.3 Market by Application
        1.3.1 Global CAR T-Cell Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hematologic Malignancies
        1.3.3 Solid Malignancies
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global CAR T-Cell Immunotherapy Market Perspective (2016-2027)
    2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
        2.2.1 CAR T-Cell Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 CAR T-Cell Immunotherapy Historic Market Share by Regions (2016-2021)
        2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027)
    2.3 CAR T-Cell Immunotherapy Industry Dynamic
        2.3.1 CAR T-Cell Immunotherapy Market Trends
        2.3.2 CAR T-Cell Immunotherapy Market Drivers
        2.3.3 CAR T-Cell Immunotherapy Market Challenges
        2.3.4 CAR T-Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top CAR T-Cell Immunotherapy Players by Revenue
        3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2016-2021)
        3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2016-2021)
    3.2 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
    3.4 Global CAR T-Cell Immunotherapy Market Concentration Ratio
        3.4.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2020
    3.5 CAR T-Cell Immunotherapy Key Players Head office and Area Served
    3.6 Key Players CAR T-Cell Immunotherapy Product Solution and Service
    3.7 Date of Enter into CAR T-Cell Immunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 CAR T-Cell Immunotherapy Breakdown Data by Type
    4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2016-2021)
    4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027)

5 CAR T-Cell Immunotherapy Breakdown Data by Application
    5.1 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2016-2021)
    5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America CAR T-Cell Immunotherapy Market Size (2016-2027)
    6.2 North America CAR T-Cell Immunotherapy Market Size by Type
        6.2.1 North America CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
        6.2.2 North America CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
        6.2.3 North America CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
    6.3 North America CAR T-Cell Immunotherapy Market Size by Application
        6.3.1 North America CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
        6.3.2 North America CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
        6.3.3 North America CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
    6.4 North America CAR T-Cell Immunotherapy Market Size by Country
        6.4.1 North America CAR T-Cell Immunotherapy Market Size by Country (2016-2021)
        6.4.2 North America CAR T-Cell Immunotherapy Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe CAR T-Cell Immunotherapy Market Size (2016-2027)
    7.2 Europe CAR T-Cell Immunotherapy Market Size by Type
        7.2.1 Europe CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
        7.2.2 Europe CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
        7.2.3 Europe CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
    7.3 Europe CAR T-Cell Immunotherapy Market Size by Application
        7.3.1 Europe CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
        7.3.2 Europe CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
        7.3.3 Europe CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
    7.4 Europe CAR T-Cell Immunotherapy Market Size by Country
        7.4.1 Europe CAR T-Cell Immunotherapy Market Size by Country (2016-2021)
        7.4.2 Europe CAR T-Cell Immunotherapy Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size (2016-2027)
    8.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type
        8.2.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
    8.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application
        8.3.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
    8.4 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region
        8.4.1 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America CAR T-Cell Immunotherapy Market Size (2016-2027)
    9.2 Latin America CAR T-Cell Immunotherapy Market Size by Type
        9.2.1 Latin America CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
        9.2.2 Latin America CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
        9.2.3 Latin America CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
    9.3 Latin America CAR T-Cell Immunotherapy Market Size by Application
        9.3.1 Latin America CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
        9.3.2 Latin America CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
        9.3.3 Latin America CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
    9.4 Latin America CAR T-Cell Immunotherapy Market Size by Country
        9.4.1 Latin America CAR T-Cell Immunotherapy Market Size by Country (2016-2021)
        9.4.2 Latin America CAR T-Cell Immunotherapy Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size (2016-2027)
    10.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type
        10.2.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2016-2027)
    10.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application
        10.3.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2016-2027)
    10.4 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country
        10.4.1 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Details
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
        11.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.1.5 AbbVie Recent Development
    11.2 Celgene
        11.2.1 Celgene Company Details
        11.2.2 Celgene Business Overview
        11.2.3 Celgene CAR T-Cell Immunotherapy Introduction
        11.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.2.5 Celgene Recent Development
    11.3 Kite Pharma
        11.3.1 Kite Pharma Company Details
        11.3.2 Kite Pharma Business Overview
        11.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
        11.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.3.5 Kite Pharma Recent Development
    11.4 Oxford BioMedica
        11.4.1 Oxford BioMedica Company Details
        11.4.2 Oxford BioMedica Business Overview
        11.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
        11.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.4.5 Oxford BioMedica Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis CAR T-Cell Immunotherapy Introduction
        11.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.5.5 Novartis Recent Development
    11.6 Gilead
        11.6.1 Gilead Company Details
        11.6.2 Gilead Business Overview
        11.6.3 Gilead CAR T-Cell Immunotherapy Introduction
        11.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.6.5 Gilead Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
        11.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.7.5 Pfizer Recent Development
    11.8 Cellectis
        11.8.1 Cellectis Company Details
        11.8.2 Cellectis Business Overview
        11.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
        11.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.8.5 Cellectis Recent Development
    11.9 Bellicum
        11.9.1 Bellicum Company Details
        11.9.2 Bellicum Business Overview
        11.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
        11.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.9.5 Bellicum Recent Development
    11.10 Mustang Bio
        11.10.1 Mustang Bio Company Details
        11.10.2 Mustang Bio Business Overview
        11.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
        11.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.10.5 Mustang Bio Recent Development
    11.11 CARsgen Therapeutics
        11.11.1 CARsgen Therapeutics Company Details
        11.11.2 CARsgen Therapeutics Business Overview
        11.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
        11.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.11.5 CARsgen Therapeutics Recent Development
    11.12 Xyphos
        11.12.1 Xyphos Company Details
        11.12.2 Xyphos Business Overview
        11.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
        11.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.12.5 Xyphos Recent Development
    11.13 Minerva Biotechnologies
        11.13.1 Minerva Biotechnologies Company Details
        11.13.2 Minerva Biotechnologies Business Overview
        11.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
        11.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.13.5 Minerva Biotechnologies Recent Development
    11.14 Adaptimmune
        11.14.1 Adaptimmune Company Details
        11.14.2 Adaptimmune Business Overview
        11.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
        11.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.14.5 Adaptimmune Recent Development
    11.15 Ziopharm Oncology
        11.15.1 Ziopharm Oncology Company Details
        11.15.2 Ziopharm Oncology Business Overview
        11.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
        11.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.15.5 Ziopharm Oncology Recent Development
    11.16 Aurora Biopharma
        11.16.1 Aurora Biopharma Company Details
        11.16.2 Aurora Biopharma Business Overview
        11.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
        11.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.16.5 Aurora Biopharma Recent Development
    11.17 Creative Biolabs
        11.17.1 Creative Biolabs Company Details
        11.17.2 Creative Biolabs Business Overview
        11.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
        11.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2016-2021)
        11.17.5 Creative Biolabs Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Monotherapy
    Table 3. Key Players of Combination Therapy
    Table 4. Global CAR T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global CAR T-Cell Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global CAR T-Cell Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global CAR T-Cell Immunotherapy Market Share by Regions (2016-2021)
    Table 8. Global CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global CAR T-Cell Immunotherapy Market Share by Regions (2022-2027)
    Table 10. CAR T-Cell Immunotherapy Market Trends
    Table 11. CAR T-Cell Immunotherapy Market Drivers
    Table 12. CAR T-Cell Immunotherapy Market Challenges
    Table 13. CAR T-Cell Immunotherapy Market Restraints
    Table 14. Global CAR T-Cell Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global CAR T-Cell Immunotherapy Market Share by Players (2016-2021)
    Table 16. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2020)
    Table 17. Ranking of Global Top CAR T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by CAR T-Cell Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players CAR T-Cell Immunotherapy Product Solution and Service
    Table 21. Date of Enter into CAR T-Cell Immunotherapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
    Table 25. Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global CAR T-Cell Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)
    Table 29. Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America CAR T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America CAR T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe CAR T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe CAR T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific CAR T-Cell Immunotherapy Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America CAR T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America CAR T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa CAR T-Cell Immunotherapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. AbbVie Company Details
    Table 62. AbbVie Business Overview
    Table 63. AbbVie CAR T-Cell Immunotherapy Product
    Table 64. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 65. AbbVie Recent Development
    Table 66. Celgene Company Details
    Table 67. Celgene Business Overview
    Table 68. Celgene CAR T-Cell Immunotherapy Product
    Table 69. Celgene Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 70. Celgene Recent Development
    Table 71. Kite Pharma Company Details
    Table 72. Kite Pharma Business Overview
    Table 73. Kite Pharma CAR T-Cell Immunotherapy Product
    Table 74. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 75. Kite Pharma Recent Development
    Table 76. Oxford BioMedica Company Details
    Table 77. Oxford BioMedica Business Overview
    Table 78. Oxford BioMedica CAR T-Cell Immunotherapy Product
    Table 79. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 80. Oxford BioMedica Recent Development
    Table 81. Novartis Company Details
    Table 82. Novartis Business Overview
    Table 83. Novartis CAR T-Cell Immunotherapy Product
    Table 84. Novartis Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 85. Novartis Recent Development
    Table 86. Gilead Company Details
    Table 87. Gilead Business Overview
    Table 88. Gilead CAR T-Cell Immunotherapy Product
    Table 89. Gilead Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 90. Gilead Recent Development
    Table 91. Pfizer Company Details
    Table 92. Pfizer Business Overview
    Table 93. Pfizer CAR T-Cell Immunotherapy Product
    Table 94. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 95. Pfizer Recent Development
    Table 96. Cellectis Company Details
    Table 97. Cellectis Business Overview
    Table 98. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 99. Cellectis Recent Development
    Table 100. Bellicum Company Details
    Table 101. Bellicum Business Overview
    Table 102. Bellicum CAR T-Cell Immunotherapy Product
    Table 103. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 104. Bellicum Recent Development
    Table 105. Mustang Bio Company Details
    Table 106. Mustang Bio Business Overview
    Table 107. Mustang Bio CAR T-Cell Immunotherapy Product
    Table 108. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 109. Mustang Bio Recent Development
    Table 110. CARsgen Therapeutics Company Details
    Table 111. CARsgen Therapeutics Business Overview
    Table 112. CARsgen Therapeutics CAR T-Cell Immunotherapy Product
    Table 113. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 114. CARsgen Therapeutics Recent Development
    Table 115. Xyphos Company Details
    Table 116. Xyphos Business Overview
    Table 117. Xyphos CAR T-Cell Immunotherapy Product
    Table 118. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 119. Xyphos Recent Development
    Table 120. Minerva Biotechnologies Company Details
    Table 121. Minerva Biotechnologies Business Overview
    Table 122. Minerva Biotechnologies CAR T-Cell Immunotherapy Product
    Table 123. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 124. Minerva Biotechnologies Recent Development
    Table 125. Adaptimmune Company Details
    Table 126. Adaptimmune Business Overview
    Table 127. Adaptimmune CAR T-Cell Immunotherapy Product
    Table 128. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 129. Adaptimmune Recent Development
    Table 130. Ziopharm Oncology Company Details
    Table 131. Ziopharm Oncology Business Overview
    Table 132. Ziopharm Oncology CAR T-Cell Immunotherapy Product
    Table 133. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 134. Ziopharm Oncology Recent Development
    Table 135. Aurora Biopharma Company Details
    Table 136. Aurora Biopharma Business Overview
    Table 137. Aurora Biopharma CAR T-Cell Immunotherapy Product
    Table 138. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 139. Aurora Biopharma Recent Development
    Table 140. Creative Biolabs Company Details
    Table 141. Creative Biolabs Business Overview
    Table 142. Creative Biolabs CAR T-Cell Immunotherapy Product
    Table 143. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2016-2021) & (US$ Million)
    Table 144. Creative Biolabs Recent Development
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CAR T-Cell Immunotherapy Market Share by Type: 2020 VS 2027
    Figure 2. Monotherapy Features
    Figure 3. Combination Therapy Features
    Figure 4. Global CAR T-Cell Immunotherapy Market Share by Application: 2020 VS 2027
    Figure 5. Hematologic Malignancies Case Studies
    Figure 6. Solid Malignancies Case Studies
    Figure 7. CAR T-Cell Immunotherapy Report Years Considered
    Figure 8. Global CAR T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 9. Global CAR T-Cell Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 10. Global CAR T-Cell Immunotherapy Market Share by Regions: 2020 VS 2027
    Figure 11. Global CAR T-Cell Immunotherapy Market Share by Regions (2022-2027)
    Figure 12. Global CAR T-Cell Immunotherapy Market Share by Players in 2020
    Figure 13. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2020
    Figure 14. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2020
    Figure 15. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)
    Figure 16. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2022-2027)
    Figure 17. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 18. North America CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 19. North America CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 20. North America CAR T-Cell Immunotherapy Market Share by Country (2016-2027)
    Figure 21. United States CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. Canada CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 25. Europe CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 26. Europe CAR T-Cell Immunotherapy Market Share by Country (2016-2027)
    Figure 27. Germany CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. France CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. U.K. CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Italy CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Russia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Nordic CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Asia-Pacific CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 35. Asia-Pacific CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 36. Asia-Pacific CAR T-Cell Immunotherapy Market Share by Region (2016-2027)
    Figure 37. China CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. South Korea CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. India CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Australia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Latin America CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 45. Latin America CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 46. Latin America CAR T-Cell Immunotherapy Market Share by Country (2016-2027)
    Figure 47. Mexico CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Brazil CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Middle East & Africa CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa CAR T-Cell Immunotherapy Market Share by Type (2016-2027)
    Figure 51. Middle East & Africa CAR T-Cell Immunotherapy Market Share by Application (2016-2027)
    Figure 52. Middle East & Africa CAR T-Cell Immunotherapy Market Share by Country (2016-2027)
    Figure 53. Turkey CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Saudi Arabia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. UAE CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 57. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 58. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 59. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 60. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 61. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 62. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 63. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 64. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 65. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 66. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 67. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 68. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 69. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 70. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 71. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 72. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Frequently Asked Questions
CAR T-Cell Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CAR T-Cell Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CAR T-Cell Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Long Acting Insulins

Long Acting Insulins (are also called basal or background insulins) can control blood sugar for a ... Read More